Jill Dolgin

Jill Dolgin

Company: AGTC

Job title: Executive Director, Global Patient Advocacy


Setting the Scene: Progress of Gene Therapy so Far in the Context of Patient Centricity 8:30 am

Patients are central to any drug development process – what makes gene therapy unique in terms of incorporating the patient voice effectively? Understanding the increased industry presence particularly within rare disease, and how this has altered stakeholder perspectives and priorities Achieving success (or failure) of gene therapy programs is impacted by how effectively patient values…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.